-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.O3.6 905. Outcomes Research-Lymphoid Malignancies: Disparities in Patient Care and Outcomes

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Access To Care, Clinical Research, Diseases, Disparities, Lymphoid Malignancies, Diversity, Equity, and Inclusion (DEI), Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value; etc.), Socioeconomic Inequities
Saturday, December 11, 2021: 4:00 PM-5:30 PM
B207-B208, Level 2, Building B (Georgia World Congress Center)
Hira S Mian, MD, McMaster University and Elizabeth Brown, The University of Alabama at Birmingham
No relevant conflicts of interest to declare.
This session will focus on disparities including gaps in trial enrollment, diagnostic and therapeutic options as well as overall patient outcomes.
4:00 PM

Lori Muffly, MD1, Jun Yin, PhD2, Sawyer Jacobson2*, Anjali Advani, MD3, Selina M. Luger, MD, FRCPC4, Martin S. Tallman, MD5, Mark R. Litzow, MD6, Matthew C. Foster, MD7, Frederick R. Appelbaum, MD8, Richard A. Larson, MD9, Theresa Keegan, Ph.D.10 and Wendy Stock11*

1Division of BMT and Cellular Therapy, Associate Professor of Medicine Bone & Marrow Transplantation Stanford University Medical Center, Stanford, CA
2Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN
3Taussig Cancer Institute / Leukemia Program, Cleveland Clinic, Cleveland, OH
4Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
5Memorial Sloan-Kettering Cancer Center, New York, NY
6Division of Hematology, Mayo Clinic, Rochester, MN
7University of North Carolina School of Medicine, Chapel Hill, NC
8Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
9Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL
10Division of Hematology/Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA
11University of Chicago, Chicago, IL

4:15 PM

Danny Luan, BS1, Christopher R. Flowers2, Brian K. Link, MD3, Jonathan W. Friedberg, MD4, Jonathon B. Cohen, MD, MS5, Brad S. Kahl, MD6, Izidore S. Lossos, MD7, Loretta Nastoupil, MD8, Matthew J. Maurer, MS9, James R. Cerhan, MD, PhD10 and Peter Martin, FRCPC, MD, MS11

1Weill Cornell Medical College, New York, NY
2Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
3Department of Medicine, University of Iowa, Iowa City, IA
4Wilmot Cancer Institute, University of Rochester, Rochester, NY
5Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
6Washington University School of Medicine in St. Louis, Saint Louis, MO
7Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
10Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
11Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY

4:30 PM

Anurekha G. Hall, MD, MS1,2, Lena E. Winestone, MD3, Erin M. Sullivan, MPH4*, Qian Vicky Wu1*, Adam J. Lamble, MD2, Mark C. Walters, MD5, Paibel Aguayo-Hiraldo, MD6*, Lourdes Baez Conde7*, Tumaini R. Coker, MD8*, Hema Dave, MD, MPH9, Dana Dornsife10*, Amy K. Keating, MD11*, Diana M. Merino12*, Bonnie Ramsey, MD13*, Julie R. Park, MD2,14* and Anurag K. Agrawal, MD15*

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA
3Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA
4Seattle Children’s Research Institute, Core for Biostatistics, Epidemiology, and Analytics in Research, Seattle, WA
5Division of Hematology, UCSF Benioff Children's Hospital Oakland, Oakland, CA
6Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA
7University of Southern California, Keck School of Medicine, Los Angeles, CA
8Department of Pediatrics, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, WA
9Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Hospital and The George Washington University, Washington, DC
10Lazarex Foundation, Danville, CA
11Pediatric Blood and Marrow Transplantation, University of Colorado, Anschutz Medical Campus Colorado Children’s Hospital, Aurora, CO
12Friends of Cancer Research, Washington DC, WA
13Department of Pediatrics, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA
14Seattle Children's Research Institute, Seattle, WA
15Division of Hematology and Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, CA

4:45 PM

Kana Tai Lucero1,2*, Obiageri O. Obodozie-Ofoegbu3,4*, Zohra Nooruddin, MD2,4, Alyssa Castillo3*, Amanda M. Moore3*, Kellie J. Ryan, MPH5*, Xavier Jones2,3,4* and Christopher R. Frei2,3,4,6*

1Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX
2South Texas Veterans Health Care System, San Antonio, TX
3College of Pharmacy, The University of Texas at Austin, San Antonio, TX
4Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX
5AstraZeneca US Medical Affairs, Gaithersburg, MD
6University Health System, San Antonio, TX

5:00 PM

Sumedha Arya, MD1, Lee Mozessohn, MD2,3,4, Inna Gong, MD, PhD1*, Neil Faught, MSc3*, Ning Liu, MSc, PhD5*, Simron Singh, MD, MPH1,2,5*, Kelvin Chan, MD, PhD2,3,4* and Matthew C. Cheung, MD, MSc2,4,5

1Department of Medicine, University of Toronto, Toronto, ON, Canada
2Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
4University of Toronto, Toronto, ON, Canada
5ICES, Toronto, ON, Canada

5:15 PM

Miriam Kwarteng-Siaw, MD1, Lauren E. Merz, MD, MSc2, Siyang Ren, MS3*, Donna S. Neuberg, ScD4, Maureen Okam Okam Achebe, MD, MPH5, Jorge A. Rodriguez, MD6* and Arielle L. Langer, MD, MPH7

1Internal Medicine, Brigham and Women's Hospital, Boston, MA
2Brigham and Women's Hospital, Boston, MA
3Department of Data Science, Boston, MA
4Department of Data Science, Dana-Farber Cancer Institute, Boston
5Division of Hematology, Hematology Division Brigham and Women's, Boston, MA
6General Internal Medicine, Brigham & Women's Hospital, Boston
7Hematology Division, Brigham and Women's Hospital, Boston, MA

*signifies non-member of ASH